Lupus Flashcards

1
Q

What are the 5 types of Lupus?

A
Subacute Lupus Erythematosus
Discoid Lupus
Drug Induced Lupus
Systemic Lupus Erythematosus
Neonatal Lupus*
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is Lupus?

A
  1. Lupus is a systemic autoimmune disease in which the body loses tolerance to self
  2. Can affect virtually any organ in the body and initial symptoms are often nonspecific, making it very difficult to diagnose
  3. Typical autoantibodies seen are those reacting against nuclear components of the cell
  4. Most commonly seen in women of childbearing age but 10% of patients are men
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Systemic Lupus Erythematosus (SLE) diagnosis/ definition

A

Prototype of auto-immune disease
Onset maybe acute, episodic, or insidious
Anything can happen to any organ system at any time.
Antinuclear antibodies are almost always present
Serositis & Immune complexes can be the hallmark and pathogenesis of the disease.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the average time to diagnose SLE?

A

Average time of two years between initial symptomatology and definitive diagnosis¹.

Analysis of stored serum of 130 military recruits who later developed lupus revealed that autoantibodies were present in the serum up to 9 years prior to the onset of clinical disease²

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Epidemiology of SLE

A

Prevalence rates 40-50 per 100,000 in U.S.

Incidence has tripled in the last 40 years

Incidence rate 2 to 8 per 100,000/year in NA, SA, and Europe

Women affected 9x more frequently- 20-40 year olds most frequent onset in age

African-Americans and Hispanics are affected more frequently than whites and have a higher disease mortality

Urban areas > rural areas

Cases of lupus increase the closer to the equator

65% of patients are between 16 and 55

20% prior to age 16, 15% after age 55

Men have a higher 1 yr mortality rate

The elderly tend to have milder SLE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

ACR Criteria for Classification of SLE

A

Rules for using the criteria:

A patient who exhibits any 4 of these 11 criteria is classified as having SLE

Criteria need not be present simultaneously 

SLE evolves over time.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the 11 ACR criteria for classification of SLE

A
  1. Malar rash 6. Serositis
  2. Discoid rash 7. Renal disorder
  3. Photosensitivity 8. Neurologic disorder
  4. Oral ulcers 9. Hematologic disorder
  5. Arthritis 10. Immunologic disorder
    11. Antinuclear antibody
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Malar Rash

A

Photosensitive
Spares nasolabial folds*
Fixed erythema, flat or raised, over malar eminences
May be hyperpigmented in darker skinned individuals

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Ddx for malar rash

A
Glucocorticoid-induced atrophy
Chloasma/ Melasma 
Benign flushing
Rosacea
Dermatitis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Mucocutaneous Lesions Patterns

A

Acute - localized or generalized

Subacute – Annular or psoriaform

Chronic – Discoid localized or generalized

Nonspecific – Vasculitis, alopecia, livedo reticularis, Raynaud’s, urticaria, lichen planus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Lupus alopecia

A
Most SLE patients
   Localized or generalized
   Scalp, eyebrows,
    eyelashes, body hair
   Increased with disease
    activity

Subsides as disease subsides

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Discoid Lupus subset

A

Patients with DLE have 90-95% do not go on to SLE

5 to 10% risk of developing SLE

This form of SLE tends to be mild

The more numerous and widespread the lesions are the higher the risk of developing SLE

Occurs in 25% of lupus patients but can occur in patients without systemic lupus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How would you describe discoid rash

A
Erythematous raised patches
Adherent keratotic scale
Follicular plugging
Atrophic scarring may occur as 
  lesions age

LOOK IN EARS!
DLE on arm
DLE in ear

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Subacute Cutaneous Lupus Subset

A
50% of patients with SCLE will have SLE
Positive anti –Ro (SS-A) and anti – LA (SS-B)
Photosensitive
Face usually spared
Nonscarring
Fatigue common
Arthralgia and arthritis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Photosensitivity

A

Skin rash as an unusual reaction to sunlight

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Mucocutaneous Ulcers

A

Oral or nasopharyngeal ulcerations

Must be observed by physician/ health care provider

Often painless

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Arthritis

A

Nonerosive arthritis involving 2
or more peripheral joints

Characterized by tenderness
swelling, or joint effusion.

18
Q

Jaccoud’s Arthropathy

A

Reducible deformities
No erosions
Periarticular fibrosis and ligamentous laxity
Swan neck deformities

19
Q

SLE - Musculoskeletal Disease

A

Arthralgia/Arthritis
Myalgia/Myositis
Ischemic necrosis of bone - AVN

20
Q

Serositis

A
  1. Pleuritis - convincing history of pleuritic pain or rub heard by a physician or evidence of pleural effusion
    or
  2. Pericarditis - documented by ECG or rub or evidence of pericardial effusion
21
Q

SLE - Pleuropulmonary disease

A
Pleuritis/Pleural effusion*
Infiltrates/Atelectasis
Acute lupus pneumonitis
Pulmonary hemorrhage
“Shrinking lung” - diaphragm dysfunction
Subclinical restrictive disease
22
Q

SLE- Cardiac Involvement

A

Pericarditis
Myocarditis
Endocarditis, Libman-Sacks
Accelerated atherosclerosis

23
Q

SLE- Renal Disorder

A
1.	Persistent proteinuria greater than 0.5 grams per day or greater than 3+ if quantitation 	not performed. Protein in the urine
Usually asymptomatic
Gross hematuria
Nephrotic syndrome
Acute renal failure
Hypertension
End stage renal failure
24
Q

SLE- Nephritis

A

Nephritis remains the most frequent cause of disease-related death.

25
Q

SLE - NEUROPSYCHIATRIC INVOLVEMENT

A
Behavior/Personality changes 
Depression
Cognitive dysfunction
Psychosis
Seizures
26
Q

Thrombocytopenic Purpura

A
Non blanching
 Purplish discoloration
 Purpura is not a disease but indicates underlying     	bleeding disorder
 Usually lower extremities
 < 1 cm is petechiae
27
Q

Hematologic D/O

A

Hemolytic anemia with reticulocytosis
OR
Leukopenia—less than 4000/mm 3 total on two separate occasions
OR
Lymphopenia—less than 1500/m 3 on two or more occasions
OR
Thrombocytopenia—less than 100,000/m 3 in the absence of
offending drugs

28
Q

Immunologic D/O

A
  1. Anti-dsDNA: antibody to native DNA in abnormal titer
    or
  2. Anti-Sm: presence of antibody to Sm nuclear antigen
    or
  3. Antiphospholipid antibodies by positive IgG or IgM anticardiolipin antibodies (not IgA) or a positive test for lupus anticoagulant, or a false positive test for syphilis (RPR) for 6 months
29
Q

SLE labs

A

Antibodies to dsDNA are present in 70% of lupus patients and are >95% specific for lupus
Anti-Sm (Smith) + in up to 30% of lupus patients and is pathognomonic
Decreased C3 and C4 indicate activity
Anti-Ro (SS-A) congenital heart block

30
Q

Antinuclear Antibodies—ANA

A

Low titer positive ANA in normal population increases with age

Patterns of ANA immunofluorescence vary.

  • SLE is commonly associated with peripheral or speckled patterns
  • Homogeneous patterns are associated with drug induced lupus.
  • First degree relatives of patients with SLE are likely to be ANA positive

32% of relatives had antinuclear antibodies, compared with 1.5% of the healthy controls

31
Q

ANA sensitivity and specificity

A

Sensitivity 95%
Specificity very low
Positive in many autoimmune diseases
10 to 35% of adults aged >65 have + ANAs
and do not have Lupus or other autoimmune disease
Negative ANA occurs in less then 3% of lupus patients, (+ SS-A or + RNP)

32
Q

ANAs do not?

A

ANAs do not correlate with disease activity

Do not forget other causes of a positive ANA

A patient with a negative ANA has less than a 3% chance of developing SLE

33
Q

Other causes for a positive ANA

A
RA, Sjogren’s, Scleroderma, Myositis
Infections (viral or bacterial)
Thyroiditis or Graves
Cancers such as melanoma, breast, lung
GI ( hepatitis, UC, Crohn’s, Primary Biliary Cirrhosis
Lung (pulmonary fibrosis, TB)
Medications
34
Q

Common manifestations not a part of ACR criteria

A

Fever and Constitutional Symptoms 42%
Raynaud’s Phenomenon 22%
Alopecia 18%
Cutaneous Vasculitis

35
Q

SLE clustering symptoms

A

Cutaneous, articular and renal manifestations tend to appear “together”

CNS thrombotic and muscular symptoms also cluster, although to a lesser extent

36
Q

Summary of Lupus

A

Do not order ANAs for broken bones
Most ANAs do not mean Lupus
Know what you are going to do with the result of an ordered lab test.
Numerous potential complications loom behind the scenes and must be anticipated and monitored
Lupus can be treated
Lupus patients can live and accomplish goals just like everyone else

37
Q

Management Goals for SLE

A

Counseling, education

Recommend adequate rest and activity (30 to 60 min pm nap)

Decrease inflammation; prevent end-organ injury failure

Preserve renal function; provide HBP Rx; prevent flare

Provide photo protection

Maintain up-to-date immunizations

Management of infection

Minimize osteoporosis

Eye examinations for Plaquenil toxicity (q 6 to 12 months)

Identify patients at risk of thrombo-occlusive events

Evaluate and treat ASHD risk; dyslipoproteinemia, etc.

Family planning/contraceptive issues

Lupus support groups and Arthritis Foundation

38
Q

Medications for SLE

A
Steroid sparing agents
	****Hydroxychloroquine (Plaquenil)
	Thalidomide (for mucocutaneous 	manifestations)
	Dapsone (for panniculitis, vasculitis)
	Danazol (for thrombocytopenia)
General Immunosuppressants
	****Azathioprine (Imuran)
	Cyclophosphamide (Cytoxan)
	Leflunomide (Arava)
	Methotrexate
	***Mycophenolate Mofetil (CellCept)
Biologics
	Abatacept (Orencia)
	Rituximab (Rituxan)
 *** Belimumab (Benlysta) NEW
Other
	IVIg
39
Q

Drug induced lupus

A
Minocycline (Minocin) 
Procainamide
Isoniazid (INH)
Phenytoin (Dilantin) 
Carbamazepine (Tegretol) 
Hydralazine (Apresoline) 
Quinidine (Quinaglute)
Infliximab, Etanercept, Adalimumab, Simponi™, Cimzia™
40
Q

Dx and treatment of drug induced lupus

A

15,000 to 20,000 new cases/yr in U.S.
Positive ANA and one clinical feature of Lupus
Antihistone antibody in 95% of cases
Fever, myalgias, rash, arthritis, serositis
Stop drug, consider anti-histone ABs
Rx with NSAIDS, steroids